The ODOL3 brand, founded in 2013 (United Kingdom), from 1722 sister brands and 17478 competing brands. ODOL3 is owned by GSK PLC, listed on the stock exchange of London The International Securities Identification Number (ISIN) of GSK PLC is GB00BN7SWP63. ODOL3 belongs to the Drug Manufacturers business sector.